- Home
- DAVA vs LNSR Comparison
DAVA vs LNSR Comparison
Compare DAVA & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAVA | LNSR |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United Kingdom | United States |
| Employees | 11225 | N/A |
| Industry | EDP Services | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 71.7M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DAVA | LNSR |
|---|---|---|
| Price | $1.49 | $4.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $3.67 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 252.5K | 65.9K |
| Earning Date | 11-24-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $4.22 |
| Revenue Next Year | $1.70 | $19.43 |
| P/E Ratio | $20.02 | ★ $8.54 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $1.50 | $4.30 |
| 52 Week High | $7.18 | $12.94 |
Technical Indicators
Market Signals| Indicator | DAVA | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 30.89 | 33.52 |
| Support Level | N/A | N/A |
| Resistance Level | $3.11 | $6.29 |
| Average True Range (ATR) | 0.13 | 0.34 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 4.31 | 38.29 |
Price Performance
Historical ComparisonAbout DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.